| Primary |
| Product Used For Unknown Indication |
27.1% |
| Routine Health Maintenance |
11.0% |
| Drug Use For Unknown Indication |
10.3% |
| Drug Exposure During Pregnancy |
7.7% |
| Medication Dilution |
5.2% |
| Breast Cancer |
4.5% |
| Bronchitis |
3.9% |
| Intravenous Catheter Management |
3.9% |
| Parenteral Nutrition |
3.2% |
| Surgery |
3.2% |
| Haemodynamic Instability |
2.6% |
| Asthma |
1.9% |
| Blood Phosphorus Decreased |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Dehydration |
1.9% |
| Hypokalaemia |
1.9% |
| Hyponatraemia |
1.9% |
| Infection |
1.9% |
| Meningitis |
1.9% |
| Osteomyelitis |
1.9% |
|
| Hyponatraemia |
18.3% |
| Vomiting |
11.3% |
| Medication Error |
8.5% |
| Necrotising Colitis |
5.6% |
| Pharmaceutical Product Complaint |
5.6% |
| Pleural Effusion |
5.6% |
| Wheezing |
5.6% |
| Wrong Drug Administered |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Anaphylactic Reaction |
2.8% |
| Bradycardia Foetal |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Incorrect Dose Administered |
2.8% |
| Pruritus |
2.8% |
| Respiratory Distress |
2.8% |
| Somnolence |
2.8% |
| Staphylococcal Infection |
2.8% |
| Throat Tightness |
2.8% |
| Tremor |
2.8% |
| Unresponsive To Stimuli |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
34.5% |
| Drug Use For Unknown Indication |
9.0% |
| Breast Cancer |
8.6% |
| Hypertension |
5.9% |
| Supplementation Therapy |
5.3% |
| Electrolyte Substitution Therapy |
4.2% |
| Arthrogram |
3.9% |
| Pain |
3.2% |
| Thrombosis Prophylaxis |
2.7% |
| Parenteral Nutrition |
2.7% |
| X-ray |
2.5% |
| Pancreatitis |
2.4% |
| Premedication |
2.3% |
| Prophylaxis |
2.3% |
| Stupor |
2.0% |
| Restlessness |
1.9% |
| Arthritis |
1.7% |
| Sedation |
1.7% |
| Fluid Replacement |
1.6% |
| X-ray Limb |
1.4% |
|
| Neuropathy Peripheral |
32.3% |
| Toxic Epidermal Necrolysis |
12.7% |
| Wrong Technique In Drug Usage Process |
10.7% |
| Stevens-johnson Syndrome |
5.5% |
| Septic Arthritis Staphylococcal |
5.2% |
| Bacteraemia |
4.1% |
| Nephropathy Toxic |
4.1% |
| Renal Failure Acute |
4.1% |
| Cardio-respiratory Arrest |
2.1% |
| Maternal Exposure During Pregnancy |
2.1% |
| Acidosis Hyperchloraemic |
1.7% |
| Gastroenteritis |
1.7% |
| Medication Error |
1.7% |
| Off Label Use |
1.7% |
| Pyrexia |
1.7% |
| Renal Salt-wasting Syndrome |
1.7% |
| Small Intestinal Obstruction |
1.7% |
| Tracheal Obstruction |
1.7% |
| Urticaria |
1.7% |
| Wrong Drug Administered |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Drug Use For Unknown Indication |
22.6% |
| Prophylaxis |
8.7% |
| Pain |
4.8% |
| Hypertension |
3.8% |
| Constipation |
3.6% |
| Nausea |
3.5% |
| Fluid Replacement |
1.9% |
| Dehydration |
1.8% |
| Premedication |
1.7% |
| Cough |
1.7% |
| Multiple Myeloma |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Dyspepsia |
1.2% |
| Anxiety |
1.2% |
| Depression |
1.2% |
| Pyrexia |
1.2% |
| Chemotherapy |
1.2% |
| Insomnia |
1.1% |
| Acute Myeloid Leukaemia |
1.1% |
|
| Vomiting |
14.6% |
| Pneumonia |
7.4% |
| Thrombocytopenia |
7.2% |
| Renal Failure Acute |
7.1% |
| Pyrexia |
6.0% |
| Sepsis |
5.8% |
| Respiratory Failure |
5.1% |
| Nausea |
5.0% |
| White Blood Cell Count Decreased |
4.8% |
| Death |
4.6% |
| Febrile Neutropenia |
4.2% |
| Renal Failure |
4.0% |
| Urinary Tract Infection |
3.6% |
| Wheezing |
3.6% |
| Dyspnoea |
3.4% |
| Pulmonary Embolism |
3.4% |
| Hypotension |
2.8% |
| Renal Impairment |
2.5% |
| Rectal Ulcer |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
|
| Interacting |
| Maternal Exposure During Pregnancy |
33.3% |
| Ill-defined Disorder |
20.0% |
| Local Anaesthesia |
20.0% |
| Foetal Exposure During Pregnancy |
16.7% |
| Anxiety |
10.0% |
|
| Tachycardia |
33.3% |
| Apgar Score Low |
16.7% |
| Drug Interaction |
16.7% |
| Foetal Heart Rate Abnormal |
16.7% |
| Injection Site Pain |
16.7% |
|
